186 related articles for article (PubMed ID: 3229323)
21. Is the endogenous digitalis-like factor the link between hypertension and metabolic disorders as diabetes mellitus, obesity and acromegaly?
Clerico A; Giampietro O
Clin Physiol Biochem; 1990; 8(3):153-68. PubMed ID: 2225723
[TBL] [Abstract][Full Text] [Related]
22. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
Graves SW; Lincoln K; Cook SL; Seely EW
Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
[TBL] [Abstract][Full Text] [Related]
23. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
Li J; Wu Z; Xu J; Zhou Y; Chu X
Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
[TBL] [Abstract][Full Text] [Related]
24. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
Li JH; Wu ZG; Xu JQ; Zhou Y
Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive endogenous digoxin-like substances: plasma levels are dependent on the hypothalamic-pituitary-adrenal axis for release and on kidney function for elimination.
Vinge E; Erfurth EM; Odar-Cederlöf I
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S112-3. PubMed ID: 7508014
[TBL] [Abstract][Full Text] [Related]
26. Endogenous digitalis-like factors (EDLF) in obese individuals: preliminary results.
Giampietro O; Clerico A; Penno G; Gregori G; Del Chicca MG; Cionini R; Volpe L; Navalesi R
J Nucl Biol Med (1991); 1992; 36(1):41-5. PubMed ID: 1333283
[TBL] [Abstract][Full Text] [Related]
27. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
Heise HR; Vorwerk P; Fritsche K; Richter R
Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
[TBL] [Abstract][Full Text] [Related]
28. [Developement and quality control of a radioimmunoassay for measurement of endogenous digoxin].
Baz MJ; Vargas F; Haro JM; Castillo MA; Jódar E; Andrade JL; García del Río C
Rev Esp Fisiol; 1990 Dec; 46(4):385-91. PubMed ID: 2099536
[TBL] [Abstract][Full Text] [Related]
29. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.
Balzan S; Montali U; Genovesi-Ebert A; Biver P; Fantoni M; Ghione S
Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327
[TBL] [Abstract][Full Text] [Related]
30. [Clinical investigation on the involvement of an endogenous digitalis-like substance in blood pressure regulation].
Takahashi H; Matsusawa M; Nishimura M; Ikegaki I; Masui I; Yamada T; Inui S; Yoshimura M
Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):53-64. PubMed ID: 2348574
[TBL] [Abstract][Full Text] [Related]
31. Relationships among endogenous digitalis-like factors in essential hypertension.
Hamlyn JM; Levinson PD; Ringel R; Levin PA; Hamilton BP; Blaustein MP; Kowarski AA
Fed Proc; 1985 Sep; 44(12):2782-8. PubMed ID: 2993039
[TBL] [Abstract][Full Text] [Related]
32. [Changes in plasma and urinary digoxin-immunoreactive like substance in normal pregnancy and pregnancy-induced hypertensive women].
Li AQ; Zhang ZJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):133-5, 187. PubMed ID: 8354089
[TBL] [Abstract][Full Text] [Related]
33. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
Dasgupta A
Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
[TBL] [Abstract][Full Text] [Related]
34. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension.
Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S
J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of endogenous digitalis-like substances in patients with pregnancy-induced hypertension].
Gao SS; Chen ZQ; Xu YQ
Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):299-302, 326-7. PubMed ID: 7953923
[TBL] [Abstract][Full Text] [Related]
36. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies.
Jakobi P; Krivoy N; Weissman A; Paldi E
Obstet Gynecol; 1989 Jul; 74(1):29-33. PubMed ID: 2733937
[TBL] [Abstract][Full Text] [Related]
37. Digitalislike immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients.
Bisordi JE; Holt S
Am J Kidney Dis; 1989 May; 13(5):396-403. PubMed ID: 2541609
[TBL] [Abstract][Full Text] [Related]
38. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
39. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
Marzullo C; Bourderont D; Dorr R
Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
[TBL] [Abstract][Full Text] [Related]
40. The role of endogenous digitalis-like factor in blood pressure regulation in essential hypertension.
Suchmanová-Lazúrová I; Lichardus B; Rosochová I; Pjescák M; Trejbal D; Murár J; Machánová Y
Wien Klin Wochenschr; 1994; 106(16):513-6. PubMed ID: 7975661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
